Results 21 to 30 of about 15,719 (229)
Public policy for meningococcal vaccination
Human Vaccines & Immunotherapeutics, 2018 On an individual basis, meningococcal disease is consistently shown to be one of the most feared potential childhood infections. On a population level, any clustering of cases or increase in disease requires proactive health protection management, while ...
J. Claire Cameron
doaj +1 more source
BMC Infectious Diseases, 2018 Background Primary meningococcal arthritis is a rare infectious disease that occurs in less than 3% of meningococcal infections and is characterized by arthritis without meningitis, fever, rash, or hemodynamic instability Barahona [Case Rep Orthop ...
S. Ricci +6 more
doaj +1 more source
A severe course of serogroup W meningococcemia in a patient with infantile nephropathic cystinosis
Human Vaccines & Immunotherapeutics, 2020 We present a 9-month old boy with cystinosis admitted to our hospital with the complaints of vomiting, diarrhea and seizure. While he was hospitalized in a pediatric intensive care unit due to worsening of his signs related to cystinosis, within hours ...
Gurkan Bozan +7 more
doaj +1 more source
Residência Pediátrica, 2023 OBJECTIVE: To describe the epidemiological profile of hospitalizations of children due to meningococcal disease in Bahia and its macro-regions, estimating morbidity and mortality due to the disease.
Vitória Pinho Lopes Cunha +3 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2023 Invasive meningococcal disease (IMD) is rare but associated with high morbidity and mortality. In the United States, the most vulnerable age groups are infants and adolescents/young adults, and the most common type of IMD is caused by serogroup B (MenB).
Jessica Presa +4 more
doaj +1 more source
Endotoxin in meningococcal infections. [PDF]
Archives of Disease in Childhood, 1980 26 children with meningococcal infections were studied to find out the relationaship between plasma and cerebrospinal fluid levels of endotoxin, the clinical outcome, the level of antigen in plasma and cerebrospinal fluid, and indices of complement activation and disseminated intravascular coagulation.
openaire +3 more sources
Human Vaccines & Immunotherapeutics, 2019 Introduction: Bacterial meningitis is one of the leading causes of morbidity and mortality among children and adults. Better understanding of the seroepidemiology of meningitis is critical for both the selection and implementation of an effective ...
Meltem Dinleyici +5 more
doaj +1 more source
N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network
Vaccines, 2016 N. meningitidis infections represent a global health problem that can lead to the development of serious permanent sequelae. Although the use of antibiotics and prevention via vaccination have reduced the incidence of meningococcal disease, our ...
Elena Gianchecchi +4 more
doaj +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow +3 more
wiley +1 more source
Harnessing the therapeutic potential of bacterial extracellular vesicles via functional peptides
Interdisciplinary Medicine, EarlyView.Bacterial extracellular vesicles (BEVs) are increasingly exploited as therapeutic agents or delivery vehicles for disease treatment due to their intrinsic structure, delivery capacity, immunogenic property, facile production, and versatile modification.
Yejiao Shi +3 more
wiley +1 more source